Found: 7
Select item for more details and to access through your institution.
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 2, p. 357, doi. 10.1007/s13402-020-00571-z
- By:
- Publication type:
- Article
SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 1899, doi. 10.3390/ijms24031899
- By:
- Publication type:
- Article
Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 3, p. 1078, doi. 10.3390/ijms21031078
- By:
- Publication type:
- Article
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01196-x
- By:
- Publication type:
- Article
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01427-8
- By:
- Publication type:
- Article
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143412
- By:
- Publication type:
- Article
Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma.
- Published in:
- Frontiers in Immunology, 2021, p. N.PAG, doi. 10.3389/fimmu.2021.622001
- By:
- Publication type:
- Article